Full-Time

Lab Assistant

Processor

Confirmed live in the last 24 hours

Veracyte

Veracyte

501-1,000 employees

Develops genomic tests for cancer diagnosis

Biotechnology
Healthcare

Compensation Overview

$18 - $23Hourly

+ Bonus + Incentives + Restricted Stock Units

Entry

Austin, TX, USA

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • Successfully completed an accredited program or have a two or four year degree
  • Previous clinical laboratory work experience preferred
  • Demonstrated ability to problem solve and proactively collaborate with peers
  • High attention to detail and dedication to customers and/or patients
Responsibilities
  • Receive and process incoming thyroid FNA samples
  • Maintain equipment and adequate stock of supplies
  • Keep work area in a safe, aseptic organized manner
  • Fulfills clerical duties which may include but not limited to specimen archival, data entry, filing
  • Process specimens using automated instrumentation and maintains Quality Assurance logs
  • Ability to troubleshoot instrumentation

Veracyte specializes in cancer diagnostics by developing advanced genomic tests that assist in the early detection and diagnosis of various cancers. Their tests analyze genetic information from non-invasive samples, such as nasal swabs or tissue biopsies, providing crucial insights into the presence and progression of cancer. This allows healthcare providers, including hospitals and clinics, to make informed treatment decisions tailored to individual patients. Veracyte differentiates itself from competitors by focusing on non-invasive testing methods and continuously investing in research to expand its product offerings. The company's goal is to improve patient outcomes and enhance the efficiency of cancer treatment through accurate and early diagnosis.

Company Stage

IPO

Total Funding

$69.4M

Headquarters

San Francisco, California

Founded

N/A

Growth & Insights
Headcount

6 month growth

5%

1 year growth

8%

2 year growth

12%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recognition as a Bay Area Top Workplace for 11 consecutive years highlights a positive work environment and strong company culture.
  • Significant investments from firms like Aigen Investment Management and Quest Partners indicate strong financial backing and growth potential.
  • The upcoming launch of ClearLab and an MRD assay in 2026 showcases Veracyte's commitment to expanding its product portfolio and market reach.

What critics are saying

  • The competitive landscape in genomic diagnostics is intense, requiring Veracyte to continuously innovate to maintain its market position.
  • Dependence on successful clinical validation and regulatory approval for new tests can pose risks to product launch timelines.

What makes Veracyte unique

  • Veracyte specializes in non-invasive genomic tests for early cancer detection, setting it apart from traditional diagnostic methods.
  • Their Decipher Prostate and Bladder Genomic Classifiers offer superior prognostic information compared to standard approaches, enhancing treatment personalization.
  • Continuous investment in R&D and clinical validation ensures that Veracyte's tests remain at the forefront of cancer diagnostics.

Help us improve and share your feedback! Did you find this helpful?